Decision and comparison guides · Updated July 2026
GLP-1 for Women: Decision and Comparison Guides
Medically reviewed by Editorial Medical Review, MD, NAMS-CMP. These are educational decision guides, not treatment recommendations.
What is here
These are decision, question, and comparison guides for women weighing GLP-1 options: which molecule fits PCOS or menopause weight gain, how Wegovy and Zepbound differ, what to know about fertility, birth control, and insurance, and which "GLP-1" products are unapproved. Each guide cites its sources and links the underlying molecule facts.
For the plain-fact explainer of each molecule (Wegovy, Zepbound, Ozempic, and the rest), see the GLP-1 for women molecule guide. To compare telehealth providers, use the provider directory. The pages below answer the decision and comparison questions those do not.
Head-to-head comparisons
Molecule-vs-molecule decision guides framed for women.
Retatrutide vs Tirzepatide for Women: Which Is Right for You?
Tirzepatide (Zepbound) is FDA-approved; retatrutide is an investigational triple agonist not yet available. How the two compare for women.
Retatrutide vs Semaglutide for Women: How They Compare
Semaglutide (Wegovy) is FDA-approved for weight; retatrutide is an investigational triple agonist not yet available. How they compare for women.
Oral vs Injectable Semaglutide: Which Should Women Choose?
Injectable semaglutide (Wegovy) is FDA-approved for weight; the Rybelsus tablet is diabetes-only. Absorption rules and women-specific notes.
Wegovy vs Zepbound for Women: Which Is Better?
Both are FDA-approved for weight: Wegovy is semaglutide, Zepbound is tirzepatide. Women-specific outcomes on contraception, cost, and trial magnitude.
By condition and life stage
PCOS, menopause, perimenopause, fertility, birth control, and age.
What Is the Best GLP-1 for PCOS?
No GLP-1 is FDA-approved for PCOS. How semaglutide and tirzepatide are used off-label for PCOS-related weight and insulin resistance.
What Is the Best GLP-1 for Menopause Weight Gain?
GLP-1 drugs are approved by BMI, not menopause status. How semaglutide and tirzepatide fit midlife weight gain, plus muscle-preservation notes.
Should You Take a GLP-1 During Perimenopause?
GLP-1 drugs are approved by BMI, not perimenopause status. How they fit fluctuating hormones, timing versus HRT, and muscle and bone considerations.
GLP-1 for Women Over 50: What to Know
What women over 50 should know about GLP-1 drugs: muscle and bone preservation, post-menopause metabolism, and BMI-based eligibility.
GLP-1 and Fertility: Planning Pregnancy on a GLP-1
Planning pregnancy on a GLP-1: label washout before conception, PCOS ovulation, and IVF timing. A GLP-1-specific decision guide for women.
GLP-1 and Birth Control: What Women Need to Know
Tirzepatide (Zepbound, Mounjaro) may reduce oral birth-control effectiveness; the label advises a backup method. Semaglutide carries no such warning.
Access, safety and buyer-beware
What works, what is a scam, timelines, and insurance how-tos.
Do GLP-1 Patches Actually Work?
No FDA-approved transdermal GLP-1 patch exists. These peptides are not absorbed through skin; online patches are unapproved. A buyer-beware verdict.
Peptides for Weight Loss for Women: What Works and What's Hype?
GLP-1 drugs are FDA-approved peptides with trial evidence. Peptides like BPC-157, tesamorelin, and AOD-9604 are not approved for weight loss.
When Will Retatrutide Be Available?
Retatrutide is investigational, with phase 3 trials ongoing and no FDA approval as of 2026. There is no confirmed launch date. What to do meanwhile.
How to Get a GLP-1 Covered by Insurance
A procedural guide to GLP-1 insurance coverage: prior authorization, appeals, BMI and comorbidity documentation, and diagnosis codes for women.
ClearHormones publishes editorial drug research and updates it as FDA status and pricing change. Verify current approval status and pricing on the manufacturer or FDA page before acting.